BRPI0414655A - composição farmacêutica, e, uso da mesma - Google Patents

composição farmacêutica, e, uso da mesma

Info

Publication number
BRPI0414655A
BRPI0414655A BRPI0414655-7A BRPI0414655A BRPI0414655A BR PI0414655 A BRPI0414655 A BR PI0414655A BR PI0414655 A BRPI0414655 A BR PI0414655A BR PI0414655 A BRPI0414655 A BR PI0414655A
Authority
BR
Brazil
Prior art keywords
composition
pharmaceutical composition
radix
extract
salviae miltiorrhizae
Prior art date
Application number
BRPI0414655-7A
Other languages
English (en)
Inventor
Feng Wei
Dekun Li
Chongnian Luo
Hongshui Yue
Qingchuang Chen
Zhijuan Huang
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of BRPI0414655A publication Critical patent/BRPI0414655A/pt
Publication of BRPI0414655B1 publication Critical patent/BRPI0414655B1/pt
Publication of BRPI0414655B8 publication Critical patent/BRPI0414655B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA, E, USO DA MESMA". A presente invenção expõe uma composição farmacêutica para o tratamento de angiocardiopatia, que consiste de 5,0% - 70,0% de extrato de Radix Salviae Miltiorrhizae, 10,0% - 85,0% de extrato de Radix Notoginseng, 5,0 - 70,0% de extrato de Radix Astragali, e de 1,0% - 15,0% de Borneol ou óleo Lignum Dalbergiae Odoriferae. A composição é ativa contra isquemia cerebral e isquemia do miocárdio. Os efeitos são superiores ao ácido fênico total de Radix Salviae Miltiorrhizae ou a saponina total de Radix Notoginseng respectivamente, ou à combinação dos mesmos. A composição da invenção pode prover vários tipos de preparação através da adição de vários acessórios. Deste modo, a invenção provê uma composição mais efetiva e conveniente de seções efetivas de TCM e suas preparações.
BRPI0414655A 2003-09-23 2004-09-23 composição farmacêutica para o tratamento de doença vascular e cérebrovascular BRPI0414655B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031443117A CN100339085C (zh) 2003-09-23 2003-09-23 治疗心脑血管疾病的中药组合物
PCT/CN2004/001085 WO2005051404A1 (en) 2003-09-23 2004-09-23 Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases

Publications (3)

Publication Number Publication Date
BRPI0414655A true BRPI0414655A (pt) 2006-11-21
BRPI0414655B1 BRPI0414655B1 (pt) 2017-03-07
BRPI0414655B8 BRPI0414655B8 (pt) 2021-05-25

Family

ID=34624426

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414655A BRPI0414655B8 (pt) 2003-09-23 2004-09-23 composição farmacêutica para o tratamento de doença vascular e cérebrovascular

Country Status (25)

Country Link
US (1) US7438935B2 (pt)
EP (1) EP1679058B1 (pt)
JP (1) JP4943846B2 (pt)
KR (1) KR20070028283A (pt)
CN (1) CN100339085C (pt)
AP (1) AP1908A (pt)
AT (1) ATE551100T1 (pt)
AU (1) AU2004292351B2 (pt)
BR (1) BRPI0414655B8 (pt)
CA (1) CA2538478C (pt)
DK (1) DK1679058T3 (pt)
EA (1) EA009730B1 (pt)
ES (1) ES2383599T3 (pt)
HK (1) HK1089092A1 (pt)
LT (1) LT5433B (pt)
MY (1) MY144043A (pt)
NO (1) NO334431B1 (pt)
NZ (1) NZ546654A (pt)
PL (1) PL1679058T3 (pt)
PT (1) PT1679058E (pt)
SA (1) SA04250309B1 (pt)
SI (1) SI1679058T1 (pt)
UA (1) UA85065C2 (pt)
WO (1) WO2005051404A1 (pt)
ZA (1) ZA200603180B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7884195B2 (en) * 2005-04-26 2011-02-08 Long Yun Li Method of extracting ginsengnoside Rg2m, pharmaceutical composition including ginsengnoside Rg2, and uses thereof
CN1305493C (zh) * 2005-06-09 2007-03-21 北京中医药大学 一种治疗脑中风的中药有效部位及其分离制备方法
EP1905444B1 (en) * 2005-07-14 2014-09-24 Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd Preparation method of a medicinal composition containing ginseng secondary glycosides
CN1919237B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 治疗心脑血管疾病的药物
CN1919238B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 一种治疗心脑血管病的药物
CN1919235B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 治疗心脑血管疾病的药物组合物
CN1919252B (zh) * 2005-08-24 2011-09-21 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物
CN1919253B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物组合物
CN1919236B (zh) * 2005-08-24 2010-09-29 天津天士力制药股份有限公司 治疗心脑血管病的药物
CN100400047C (zh) * 2006-04-05 2008-07-09 黑龙江省珍宝岛制药有限公司 一种用于治疗心脑血管疾病的粉针剂及其制备方法和应用
CN100563662C (zh) * 2006-11-28 2009-12-02 中国科学院上海药物研究所 治疗心血管疾病的中药有效成分组合物及其制备方法
CN101322801B (zh) 2007-06-15 2011-07-20 河北以岭医药研究院有限公司 一种中药组合物在制备治疗扩张型心肌病药物中的应用
CN101439079B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含黄芪总皂甙的中药颗粒的制备方法
CN101439076B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含降香油的中药颗粒的制备方法
CN101439078B (zh) * 2007-11-22 2012-03-28 天津天士力制药股份有限公司 一种含黄芪提取物的中药颗粒及其制备方法
CN101524352A (zh) 2008-03-04 2009-09-09 江苏先声药物研究有限公司 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物
EP2415749B1 (en) * 2009-03-30 2016-05-04 Tasly Pharmaceutical Group Co., Ltd. New salvianolic acid compound l, preparation method and use thereof
CN102028739B (zh) * 2009-09-29 2014-01-29 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及其制备方法
CN102028748A (zh) * 2009-09-29 2011-04-27 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及提取工艺
KR101286870B1 (ko) 2009-11-30 2013-07-16 (주)아모레퍼시픽 황기 추출물을 포함하는 대사 촉진 조성물
CN102160872A (zh) * 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
CN102293821A (zh) * 2010-06-28 2011-12-28 天津天士力制药股份有限公司 一种中药组合物在制备减轻急性心肌梗死后心绞痛发作的药物中的应用
JP6030556B2 (ja) 2010-08-06 2016-11-24 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッドＴａｓｌｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 冠動脈心疾患の二次予防薬の調製におけるタンジン組成物の使用
CN102670759A (zh) * 2012-05-18 2012-09-19 王显 治疗动脉粥样硬化的中药组合物
KR20140080289A (ko) * 2012-12-20 2014-06-30 대전대학교 산학협력단 산화적 뇌손상 및 뇌기능 장애의 예방 또는 치료용 조성물 및 이의 제조방법
CN103070909B (zh) * 2013-01-04 2015-07-29 云南金七制药有限公司 三芪软胶囊及其制备方法
MX2015017651A (es) * 2013-07-11 2016-11-14 Tasly Pharmaceutical Group Co Formulacion de una pildora por goteo y el metodo de preparacion de la misma.
WO2015003662A1 (zh) 2013-07-11 2015-01-15 天士力制药集团股份有限公司 一种中药组合物及其制剂和用途
GEP20186877B (en) 2013-07-11 2018-07-10 Tasly Pharmaceutical Group Co Traditional chinese medicine composition, and preparation and application thereof
CN104418744B (zh) 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104013831B (zh) * 2014-06-05 2017-06-23 黄艳梅 一种治疗脑供血不足的药物
CN106632572B (zh) * 2016-12-16 2018-08-14 中国科学院成都生物研究所 一种黄芪甲苷衍生物及其制备方法和应用
KR101892392B1 (ko) 2017-06-12 2018-08-27 오형근 고혈압 및 당뇨 개선을 위한 조성물
CN107582977A (zh) * 2017-10-18 2018-01-16 海南梵思科技有限公司 一种治疗心血管疾病的中药组合物及其制备方法
FR3076458B1 (fr) * 2018-01-05 2022-06-24 Soc Ind Limousine Dapplication Biologique Utilisation cosmetique d'extraits de racines de salvia miltiorrhiza, extraits particuliers de racines de salvia miltiorrhiza et compositions cosmetiques incluant de tels extraits
TW201944990A (zh) * 2018-04-04 2019-12-01 大陸商天士力醫藥集團股份有限公司 預防和/或治療缺血再灌注損傷的中藥組合物及其製劑和應用
CN109394832A (zh) * 2018-10-29 2019-03-01 华玉海 一种治疗心脑血管病的复方滴丸及其制备方法
CA3167884A1 (en) * 2020-04-29 2021-11-04 He SUN Application of a traditional chinese medicine composition and formulation thereof in the preparation of medicaments for preventing and/or treating novel coronavirus pneumonia
CN113925892B (zh) * 2020-06-29 2024-04-09 天士力医药集团股份有限公司 中药芪参益气制剂治疗胃出血的用途
CN111991533A (zh) * 2020-09-11 2020-11-27 吉林省中医药科学院（吉林省中医药科学院第一临床医院） 一种治疗冠心病的中药组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577943B1 (de) 1992-06-29 1996-06-26 Elpatronic Ag Verfahren zum Zuführen von Dosenzargen zu einer Dosenschweissstation sowie Vorrichtung zu dessen Durchführung
CN1025774C (zh) * 1992-11-14 1994-08-31 连汝安 一种特效型山海丹及其生产方法
CN1041494C (zh) * 1993-01-01 1999-01-06 河南省中药研究所 用于治疗慢性缺血性心脏病的一种中药散剂胶囊
CN1074613A (zh) * 1993-01-18 1993-07-28 邱天道 心泰膏
CN1085083C (zh) * 1993-02-17 2002-05-22 山海丹企业集团西安中医多学科研究所 治疗心绞痛型冠心病的药物及生产方法
CN1067244C (zh) * 1996-02-17 2001-06-20 昆明制药股份有限公司 三七皂甙粉针剂
CN1242364A (zh) 1998-07-22 2000-01-26 中国医科大学 治疗消化性溃疡的丹参提取物f及其制备工艺
CN1129572C (zh) 1998-09-11 2003-12-03 中国科学院上海药物研究所 丹参多酚酸盐混合物及其制备方法和用途
CN1095363C (zh) * 1999-05-05 2002-12-04 方同华 精制血塞通注射液的生产工艺
CN1274600A (zh) * 1999-05-24 2000-11-29 周金龙 一种治疗瘫痪的药物及其制备方法
CN1095674C (zh) * 1999-06-18 2002-12-11 贺云青 一种治疗脑血管病及风湿类风湿病的中草药组合物
CN1363288A (zh) * 2001-01-10 2002-08-14 杨孟君 纳米消栓再造制剂药物及其制备方法
CN1368061A (zh) * 2001-01-31 2002-09-11 杨孟君 纳米消栓通络制剂药物及其制备方法
WO2002092109A1 (en) * 2001-05-14 2002-11-21 The Affiliated Hospital Of Chengdu University Of Traditional Chinese Medicine Herbal composition and its use
US6589572B2 (en) * 2001-06-14 2003-07-08 Medvill Co., Ltd. Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same
US6616943B2 (en) * 2001-08-31 2003-09-09 Fountain Silver Limited Composition comprising Wenguanguo extracts and methods for preparing same
CN1229324C (zh) * 2001-09-26 2005-11-30 中国医学科学院药物研究所 丹参总酚酸的提取方法及其制剂的制法与用途
TWI275396B (en) * 2001-10-17 2007-03-11 Braingenesis Biotechnology Co Composition of traditional Chinese medicines for preventing and treating cerebrovascular disease
CN1349818A (zh) * 2001-10-24 2002-05-22 沈阳药科大学 复方丹参有效部位群及其缓释制剂与医药用途和制备方法
CN1352985A (zh) 2001-11-27 2002-06-12 沈阳药科大学 中药丹参有效部位及其缓释制剂与医药用途和制备方法
CN1248702C (zh) * 2002-02-07 2006-04-05 天津天士力制药股份有限公司 治疗冠心病心绞痛的中药制剂及其制备方法
CN1202103C (zh) 2002-05-23 2005-05-18 天津天士力制药股份有限公司 丹参总酚酸的制备方法

Also Published As

Publication number Publication date
EP1679058A4 (en) 2009-12-09
CN100339085C (zh) 2007-09-26
EA200600636A1 (ru) 2006-08-25
MY144043A (en) 2011-07-29
CA2538478A1 (en) 2005-06-09
US7438935B2 (en) 2008-10-21
ES2383599T3 (es) 2012-06-22
CA2538478C (en) 2013-02-19
LT5433B (lt) 2007-07-25
NO334431B1 (no) 2014-03-03
AU2004292351B2 (en) 2009-11-19
KR20070028283A (ko) 2007-03-12
SA04250309B1 (ar) 2009-12-22
EP1679058B1 (en) 2012-03-28
DK1679058T3 (da) 2012-06-25
WO2005051404A8 (fr) 2006-04-27
AP2006003596A0 (en) 2006-04-30
PT1679058E (pt) 2012-06-28
ZA200603180B (en) 2007-01-31
BRPI0414655B8 (pt) 2021-05-25
UA85065C2 (ru) 2008-12-25
EP1679058A1 (en) 2006-07-12
AP1908A (en) 2008-10-24
ATE551100T1 (de) 2012-04-15
AU2004292351A1 (en) 2005-06-09
SI1679058T1 (sl) 2012-07-31
NO20061764L (no) 2006-05-22
BRPI0414655B1 (pt) 2017-03-07
PL1679058T3 (pl) 2012-09-28
CN1600319A (zh) 2005-03-30
JP2007505936A (ja) 2007-03-15
NZ546654A (en) 2008-09-26
US20070053999A1 (en) 2007-03-08
HK1089092A1 (en) 2006-11-24
WO2005051404A1 (en) 2005-06-09
EA009730B1 (ru) 2008-02-28
JP4943846B2 (ja) 2012-05-30
LT2006027A (lt) 2007-03-26

Similar Documents

Publication Publication Date Title
BRPI0414655A (pt) composição farmacêutica, e, uso da mesma
AU2015101908A4 (en) Cannabis-based extracts and topical formulations for use in skin disorders
Jeong et al. Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract
Park et al. An anti-inflammatory principle from cactus
Manjrekar et al. Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl 4 induced hepatotoxic rats
BRPI0507895A (pt) composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
NO20070578L (no) Oral doseringsform sikret mot misbruk inneholdende (1,2R)-3-(3-dimetylammino-l-etyl-2-metyl-propyl)-fenol
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
Umeh et al. Wound-healing activity of the aqueous leaf extract and fractions of Ficus exasperata (Moraceae) and its safety evaluation on albino rats
BR9911073A (pt) Uso de uma composição compreendendo formoterol e budesonida para a prevenção ou tratamento de uma condição aguda de asma
JP2007512271A (ja) アトピー性皮膚炎、皮膚のアレルギー状態、および座瘡の治療用組成物
CA2218766A1 (fr) Composes bicycliques-aromatiques
Parthasarathy et al. The potential effect of phytochemicals and herbal plant remedies for treating drug-induced hepatotoxicity: a review
CA2264979A1 (fr) Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
El-Maadawy et al. 6-Paradol alleviates Diclofenac-induced acute kidney injury via autophagy enhancement-mediated by AMPK/AKT/mTOR and NLRP3 inflammasome pathways
Zahra et al. Hepatoprotective role of extracts of Momordica charantia L. in acetaminophen-induced toxicity in rabbits.
BR9812604A (pt) Composição para suprimir os sintomas da retirada e do desejo insaciável pelo álcool em alcoólatras e para evitar o abuso do álcool em indivìduos saudáveis
CA2334843A1 (fr) Composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
Gilani et al. Studies on bronchodilator activity of salvia officinalis (Sage): possible involvement of K+ channel activation and phosphodiesterase inhibition
BRPI0418224A (pt) composição que compreende um extrato aquoso de folhas de videira-vermelha e um agente antitrombótico para o tratamento de insuficiências venosas crÈnicas
Roy et al. An insight into the ethnopharmacological importance of Indian subcontinent medicinal plant species of Rubiaceae family
BRPI0401592A (pt) Extrato diclorometânico de "bidens alba l." com atividades anti-ulcerogênicas dos sesquiterpenos e poliacetilenos
JPH03251538A (ja) 外用鎮痒剤
Nagar Hepatoprotective effects of Cyathula Prostrata Linn. in paracetamol induced liver injury in rats

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: TIANJIN TASLY PHARMACEUTICAL CO., LTD. (CN)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 20140017033/RJ, DE 12/05/2014, E NECESSARIO APRESENTAR O DOCUMENTO COM A DEVIDA LEGALIZACAO CONSULAR.

B25D Requested change of name of applicant approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B25G Requested change of headquarter approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 9/00

Ipc: A61K 36/537 (2006.01), A61K 36/258 (2006.01), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/09/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2689 DE 19-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.